Bausch Health Companies Inc. Financing Cash Flow
Bausch Health Companies Inc. (BHC) reported Financing Cash Flow of -$149.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-07-30
- Bausch Health Companies Inc. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was -$49.00M, a 113.69% decline year-over-year.
- Bausch Health Companies Inc. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was -$100.00M.
- Bausch Health Companies Inc. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was -$235.00M, a 376.47% decline year-over-year.
- Bausch Health Companies Inc. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was -$719.00M.
- Bausch Health Companies Inc. net cash provided by (used in) financing activities for fiscal 2025 was -$742.00M.
- Bausch Health Companies Inc. net cash provided by (used in) financing activities for fiscal 2024 was -$868.00M, a 158.85% decline from fiscal 2023.
- Bausch Health Companies Inc. net cash provided by (used in) financing activities for fiscal 2023 was $1.48B.
- Bausch Health Companies Inc. net cash provided by (used in) financing activities for fiscal 2022 was -$474.00M.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 3 month as first filed | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 6 month as first filed | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 9 month as first filed | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$49.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | -$149.00M 10-Q · filed 2026-07-30 | -$384.00M derived: sum of 3 quarters · filed 2026-07-30 | -$1.10B derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2026-03-31 | -$100.00M 10-Q · filed 2026-04-30 | -$335.00M derived: sum of 2 quarters · filed 2026-04-30 | -$1.05B derived: sum of 3 quarters · filed 2026-04-30 | -$696.00M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-12-31 | -$235.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$954.00M derived: sum of 2 quarters · filed 2026-02-19 | -$596.00M derived: sum of 3 quarters · filed 2026-07-30 | -$742.00M 10-K · filed 2026-02-19 | ||||
| 2025-09-30 | -$719.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | -$361.00M derived: sum of 2 quarters · filed 2026-07-30 | -$507.00M 10-Q · filed 2025-10-30 | -$422.00M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-06-30 | $358.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $212.00M 10-Q · filed 2026-07-30 | $297.00M derived: sum of 3 quarters · filed 2026-07-30 | $108.00M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-03-31 | -$146.00M 10-Q · filed 2026-04-30 | -$61.00M derived: sum of 2 quarters · filed 2026-04-30 | -$250.00M derived: sum of 3 quarters · filed 2026-04-30 | -$674.00M derived: sum of 4 quarters · filed 2026-04-30 | ||||
| 2024-12-31 | $85.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$104.00M derived: sum of 2 quarters · filed 2026-02-19 | -$528.00M derived: sum of 3 quarters · filed 2026-02-19 | -$868.00M 10-K · filed 2026-02-19 | ||||
| 2024-09-30 | -$189.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | -$613.00M derived: sum of 2 quarters · filed 2025-10-30 | -$953.00M 10-Q · filed 2025-10-30 | -$1.03B derived: sum of 4 quarters · filed 2026-02-19 | ||||
| 2024-06-30 | -$424.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | -$764.00M 10-Q · filed 2025-07-31 | -$843.00M derived: sum of 3 quarters · filed 2026-02-19 | $973.00M derived: sum of 4 quarters · filed 2026-02-19 | ||||
| 2024-03-31 | -$340.00M 10-Q · filed 2025-05-01 | -$419.00M derived: sum of 2 quarters · filed 2026-02-19 | $1.40B derived: sum of 3 quarters · filed 2026-02-19 | $1.28B derived: sum of 4 quarters · filed 2026-02-19 | ||||
| 2023-12-31 | -$79.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $1.74B derived: sum of 2 quarters · filed 2026-02-19 | $1.62B derived: sum of 3 quarters · filed 2026-02-19 | $1.48B 10-K · filed 2026-02-19 | ||||
| 2023-09-30 | $1.82B derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $1.70B derived: sum of 2 quarters · filed 2024-10-31 | $1.55B 10-Q · filed 2024-10-31 | $1.28B derived: sum of 4 quarters · filed 2025-02-20 | ||||
| 2023-06-30 | -$120.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | -$262.00M 10-Q · filed 2024-08-01 | -$538.00M derived: sum of 3 quarters · filed 2025-02-20 | -$574.00M derived: sum of 4 quarters · filed 2025-02-20 | ||||
| 2023-03-31 | -$142.00M 10-Q · filed 2024-05-02 | -$418.00M derived: sum of 2 quarters · filed 2025-02-20 | -$454.00M derived: sum of 3 quarters · filed 2025-02-20 | -$1.08B derived: sum of 4 quarters · filed 2025-02-20 | ||||
| 2022-12-31 | -$276.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | -$312.00M derived: sum of 2 quarters · filed 2025-02-20 | -$942.00M derived: sum of 3 quarters · filed 2025-02-20 | -$474.00M 10-K · filed 2025-02-20 | ||||
| 2022-09-30 | -$36.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | -$666.00M derived: sum of 2 quarters · filed 2023-11-02 | -$198.00M 10-Q · filed 2023-11-02 | $77.00M derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2022-06-30 | -$630.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$162.00M 10-Q · filed 2023-08-03 | $113.00M derived: sum of 3 quarters · filed 2024-02-22 | -$1.04B derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2022-03-31 | $468.00M 10-Q · filed 2023-05-04 | $743.00M derived: sum of 2 quarters · filed 2024-02-22 | -$414.00M derived: sum of 3 quarters · filed 2024-02-22 | -$802.00M derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2021-12-31 | $275.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | -$882.00M derived: sum of 2 quarters · filed 2024-02-22 | -$1.27B derived: sum of 3 quarters · filed 2024-02-22 | -$1.51B 10-K · filed 2024-02-22 | ||||
| 2021-09-30 | -$1.16B derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$1.54B derived: sum of 2 quarters · filed 2022-11-03 | -$1.79B 10-Q · filed 2022-11-03 | -$2.29B derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2021-06-30 | -$388.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$631.00M 10-Q · filed 2022-08-09 | -$1.13B derived: sum of 3 quarters · filed 2023-02-23 | -$1.25B derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2021-03-31 | -$243.00M 10-Q · filed 2022-05-10 | -$746.00M derived: sum of 2 quarters · filed 2023-02-23 | -$863.00M derived: sum of 3 quarters · filed 2023-02-23 | -$1.02B derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2020-12-31 | -$503.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | -$620.00M derived: sum of 2 quarters · filed 2023-02-23 | -$773.00M derived: sum of 3 quarters · filed 2023-02-23 | -$2.29B 10-K · filed 2023-02-23 | ||||
| 2020-09-30 | -$117.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | -$270.00M derived: sum of 2 quarters · filed 2021-11-02 | -$1.79B 10-Q · filed 2021-11-02 | $464.00M derived: sum of 4 quarters · filed 2022-05-11 | ||||
| 2020-06-30 | -$153.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | -$1.67B 10-Q · filed 2021-08-03 | $581.00M derived: sum of 3 quarters · filed 2022-05-11 | $107.00M derived: sum of 4 quarters · filed 2022-05-11 | ||||
| 2020-03-31 | -$1.52B 10-Q · filed 2021-05-04 | $734.00M derived: sum of 2 quarters · filed 2022-05-11 | $260.00M derived: sum of 3 quarters · filed 2022-05-11 | $72.00M derived: sum of 4 quarters · filed 2022-05-11 | ||||
| 2019-12-31 | $2.25B derived: 8-K 12 month − 10-Q 9 month · filed 2022-05-11 | $1.78B derived: sum of 2 quarters · filed 2022-05-11 | $1.59B derived: sum of 3 quarters · filed 2022-05-11 | $1.44B 8-K · filed 2022-05-11 | ||||
| 2019-09-30 | -$474.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-03 | -$662.00M derived: sum of 2 quarters · filed 2020-11-03 | -$812.00M 10-Q · filed 2020-11-03 | -$1.31B derived: sum of 4 quarters · filed 2021-05-04 | ||||
| 2019-06-30 | -$188.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$338.00M 10-Q · filed 2020-08-06 | -$840.00M derived: sum of 3 quarters · filed 2021-05-04 | -$1.23B derived: sum of 4 quarters · filed 2021-05-04 | ||||
| 2019-03-31 | -$150.00M 10-Q · filed 2020-05-07 | -$652.00M derived: sum of 2 quarters · filed 2021-05-04 | -$1.04B derived: sum of 3 quarters · filed 2021-05-04 | -$1.22B derived: sum of 4 quarters · filed 2021-05-04 | ||||
| 2018-12-31 | -$502.00M derived: 8-K 12 month − 10-Q 9 month · filed 2021-05-04 | -$888.00M derived: sum of 2 quarters · filed 2021-05-04 | -$1.06B derived: sum of 3 quarters · filed 2021-05-04 | -$1.35B 8-K · filed 2021-05-04 | ||||
| 2018-09-30 | -$386.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | -$563.00M derived: sum of 2 quarters · filed 2019-11-04 | -$851.00M 10-Q · filed 2019-11-04 | -$2.69B derived: sum of 4 quarters · filed 2020-02-19 | ||||
| 2018-06-30 | -$177.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | -$465.00M 10-Q · filed 2019-08-06 | -$2.31B derived: sum of 3 quarters · filed 2020-02-19 | -$3.74B derived: sum of 4 quarters · filed 2020-02-19 | ||||
| 2018-03-31 | -$288.00M 10-Q · filed 2019-05-06 | -$2.13B derived: sum of 2 quarters · filed 2020-02-19 | -$3.56B derived: sum of 3 quarters · filed 2020-02-19 | -$3.81B derived: sum of 4 quarters · filed 2020-02-19 | ||||
| 2017-12-31 | -$1.84B derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19 | -$3.27B derived: sum of 2 quarters · filed 2020-02-19 | -$3.52B derived: sum of 3 quarters · filed 2020-02-19 | -$4.96B 10-K · filed 2020-02-19 | ||||
| 2017-09-30 | -$1.43B derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | -$1.68B derived: sum of 2 quarters · filed 2018-11-06 | -$3.12B 10-Q · filed 2018-11-06 | -$3.70B derived: sum of 4 quarters · filed 2019-02-20 | ||||
| 2017-06-30 | -$249.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | -$1.69B 10-Q · filed 2018-08-07 | -$2.27B derived: sum of 3 quarters · filed 2019-02-20 | -$2.96B derived: sum of 4 quarters · filed 2019-02-20 | ||||
| 2017-03-31 | -$1.44B 10-Q · filed 2018-05-08 | -$2.02B derived: sum of 2 quarters · filed 2019-02-20 | -$2.71B derived: sum of 3 quarters · filed 2019-02-20 | -$3.67B derived: sum of 4 quarters · filed 2019-02-20 | ||||
| 2016-12-31 | -$575.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-20 | -$1.27B derived: sum of 2 quarters · filed 2019-02-20 | -$2.22B derived: sum of 3 quarters · filed 2019-02-20 | -$1.96B 10-K · filed 2019-02-20 | ||||
| 2016-09-30 | -$697.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | -$1.65B derived: sum of 2 quarters · filed 2017-11-07 | -$1.39B 10-Q · filed 2017-11-07 | -$1.39B 10-Q · filed 2016-11-09 | -$1.27B derived: sum of 4 quarters · filed 2018-08-10 | |||
| 2016-06-30 | -$951.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | -$691.00M 10-Q · filed 2017-08-08 | -$692.30M 10-Q · filed 2016-08-09 | -$568.50M derived: sum of 3 quarters · filed 2018-08-10 | -$677.00M derived: sum of 4 quarters · filed 2018-08-10 | |||
| 2016-03-31 | $260.00M 10-Q · filed 2017-05-09 | $259.20M 10-Q · filed 2016-06-07 | $382.50M derived: sum of 2 quarters · filed 2018-08-10 | $274.00M derived: sum of 3 quarters · filed 2018-08-10 | $1.60B derived: sum of 4 quarters · filed 2018-08-10 | |||
| 2015-12-31 | $122.50M derived: 8-K 12 month − 10-Q 9 month · filed 2018-08-10 | $14.00M derived: sum of 2 quarters · filed 2018-08-10 | $1.34B derived: sum of 3 quarters · filed 2018-08-10 | $13.62B 8-K · filed 2018-08-10 | $13.68B 10-K · filed 2016-04-29 | |||
| 2015-09-30 | -$108.50M 10-Q · filed 2015-10-26 | $1.22B derived: sum of 2 quarters · filed 2015-10-26 | $13.50B 10-Q · filed 2016-11-09 | $13.52B 10-Q · filed 2015-10-26 | $12.42B derived: sum of 4 quarters · filed 2017-03-01 | |||
| 2015-06-30 | $1.33B 10-Q · filed 2015-07-28 | $13.63B 10-Q · filed 2016-08-09 | $12.53B derived: sum of 3 quarters · filed 2017-03-01 | $11.45B derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2015-03-31 | $12.31B 10-Q · filed 2016-06-07 | $11.21B derived: sum of 2 quarters · filed 2017-03-01 | $10.13B derived: sum of 3 quarters · filed 2017-03-01 | $9.97B derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2014-12-31 | -$1.10B derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | -$2.18B derived: sum of 2 quarters · filed 2017-03-01 | -$2.34B derived: sum of 3 quarters · filed 2017-03-01 | -$2.46B 10-K · filed 2017-03-01 | -$2.44B 10-K · filed 2015-02-25 | |||
| 2014-09-30 | -$1.08B 10-Q · filed 2015-10-26 | -$1.24B derived: sum of 2 quarters · filed 2015-10-26 | -$1.36B 10-Q · filed 2015-10-26 | |||||
| 2014-06-30 | -$156.60M 10-Q · filed 2015-07-28 | -$279.30M 10-Q · filed 2015-07-28 | ||||||
| 2014-03-31 | -$122.70M 10-Q · filed 2015-04-30 | |||||||
| 2013-12-31 | $4.03B 10-K · filed 2016-04-29 | |||||||
| 2012-12-31 | $3.06B 10-K · filed 2015-02-25 | |||||||
| 2011-06-30 | -$330.17M 10-Q · filed 2011-08-08 | $412.60M 10-Q · filed 2011-08-08 | $248.11M derived: sum of 3 quarters · filed 2011-08-08 | $237.52M derived: sum of 4 quarters · filed 2011-08-08 | ||||
| 2011-03-31 | $742.77M 10-Q · filed 2011-05-10 | $578.28M derived: sum of 2 quarters · filed 2011-05-10 | $567.69M derived: sum of 3 quarters · filed 2011-05-10 | $542.19M derived: sum of 4 quarters · filed 2011-08-08 | ||||
| 2010-12-31 | -$164.49M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-28 | -$175.08M derived: sum of 2 quarters · filed 2011-02-28 | -$200.58M derived: sum of 3 quarters · filed 2011-08-08 | -$213.28M 10-K · filed 2011-02-28 | ||||
| 2010-09-30 | -$10.59M 10-Q · filed 2010-11-05 | -$36.09M derived: sum of 2 quarters · filed 2011-08-08 | -$48.79M 10-Q · filed 2010-11-05 | -$117.22M derived: sum of 4 quarters · filed 2011-08-08 | ||||
| 2010-06-30 | -$25.50M 10-Q · filed 2011-08-08 | -$38.20M 10-Q · filed 2011-08-08 | -$106.63M derived: sum of 3 quarters · filed 2011-08-08 | -$195.85M derived: sum of 4 quarters · filed 2011-08-08 | ||||
| 2010-03-31 | -$12.70M 10-Q · filed 2011-05-10 | -$81.13M derived: sum of 2 quarters · filed 2011-05-10 | -$170.34M derived: sum of 3 quarters · filed 2011-05-10 | $223.68M derived: sum of 4 quarters · filed 2011-05-10 | ||||
| 2009-12-31 | -$68.43M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-28 | -$157.64M derived: sum of 2 quarters · filed 2011-02-28 | $236.38M derived: sum of 3 quarters · filed 2011-02-28 | $177.05M 10-K · filed 2011-02-28 | ||||
| 2009-09-30 | -$89.21M 10-Q · filed 2010-11-05 | $304.81M derived: sum of 2 quarters · filed 2010-11-05 | $245.47M 10-Q · filed 2010-11-05 | |||||
| 2009-06-30 | $394.02M 10-Q · filed 2010-08-06 | $334.69M 10-Q · filed 2010-08-06 | ||||||
| 2008-12-31 | -$210.31M 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 |